Based on this exhaustive list, it appears that NP may finally drop the Philippines EUA pitch until at least leronlimab recieves EUA here in the U.S. That never seemed likely before CD12 readout and evening less likely when the Filipino FDA released the standards for EUA which clearly states an EUA from the U.S. is required as part of the application.